全文获取类型
收费全文 | 37277篇 |
免费 | 2269篇 |
国内免费 | 1119篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 944篇 |
妇产科学 | 679篇 |
基础医学 | 1926篇 |
口腔科学 | 71篇 |
临床医学 | 4226篇 |
内科学 | 10809篇 |
皮肤病学 | 61篇 |
神经病学 | 1049篇 |
特种医学 | 881篇 |
外科学 | 2595篇 |
综合类 | 7324篇 |
预防医学 | 2044篇 |
眼科学 | 700篇 |
药学 | 5298篇 |
27篇 | |
中国医学 | 1779篇 |
肿瘤学 | 182篇 |
出版年
2023年 | 467篇 |
2022年 | 566篇 |
2021年 | 981篇 |
2020年 | 1299篇 |
2019年 | 1022篇 |
2018年 | 1081篇 |
2017年 | 1104篇 |
2016年 | 1147篇 |
2015年 | 1169篇 |
2014年 | 2555篇 |
2013年 | 3420篇 |
2012年 | 2104篇 |
2011年 | 2198篇 |
2010年 | 1906篇 |
2009年 | 1695篇 |
2008年 | 1660篇 |
2007年 | 1810篇 |
2006年 | 1626篇 |
2005年 | 1358篇 |
2004年 | 1260篇 |
2003年 | 1154篇 |
2002年 | 949篇 |
2001年 | 944篇 |
2000年 | 799篇 |
1999年 | 669篇 |
1998年 | 551篇 |
1997年 | 614篇 |
1996年 | 495篇 |
1995年 | 536篇 |
1994年 | 452篇 |
1993年 | 310篇 |
1992年 | 331篇 |
1991年 | 272篇 |
1990年 | 236篇 |
1989年 | 211篇 |
1988年 | 217篇 |
1987年 | 183篇 |
1986年 | 171篇 |
1985年 | 212篇 |
1984年 | 195篇 |
1983年 | 103篇 |
1982年 | 123篇 |
1981年 | 122篇 |
1980年 | 127篇 |
1979年 | 63篇 |
1978年 | 44篇 |
1977年 | 47篇 |
1976年 | 40篇 |
1974年 | 16篇 |
1973年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
目的探讨老年高血压患者应用厄贝沙坦联合苯磺酸氨氯地平治疗的临床效果。方法76例老年高血压患者,采用随机数字表法分为观察组和对照组,各38例。对照组患者采用苯磺酸氨氯地平片治疗,观察组采用厄贝沙坦联合苯磺酸氨氯地平治疗治疗。比较两组临床疗效、不良反应发生率及治疗前后血压[收缩压(SBP)、舒张压(DBP)]、血脂[总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)]水平。结果治疗前,两组SBP、DBP水平比较,差异无统计学意义(P>0.05);治疗后,观察组SBP(133.16±5.08)mm Hg(1 mm Hg=0.133 kPa)、DBP(72.35±2.19)mm Hg均低于对照组的(141.95±6.19)、(80.95±3.86)mm Hg,差异有统计学意义(P<0.05)。观察组治疗总有效率为97.37%,高于对照组的81.58%,差异有统计学意义(P<0.05)。治疗前,两组TC、TG、LDL-C、HDL-C水平比较差异无统计学意义(P>0.05);治疗后,观察组TC、TG、LDL-C水平均低于对照组,HDL-C水平高于对照组,差异有统计学意义(P<0.05)。观察组不良反应率5.26%与对照组的7.89%比较,差异无统计学意义(P>0.05)。结论对老年高血压患者采用厄贝沙坦联合苯磺酸氨氯地平治疗可进一步提升疗效,有效控制血压及血脂水平,其安全性良好。 相似文献
2.
目的 探讨急诊介入栓塞治疗对于急性重度静脉曲张上消化道出血(ASVUGIB)患者的临床价值。方法 收集直接或补救介入治疗的48例ASVUGIB患者数据。按急诊介入原因分为直接介入治疗组(40例)及补救性介入治疗组(8例), 对经DSA明确造影剂外溢的直接出血征象患者行经皮经肝/经脾门静脉造影+曲张静脉栓塞术+ 经颈静脉肝内门体分流术(TIPS);对经DSA未发现明确出血征象的患者行经皮经肝/经脾门静脉造影+曲张静脉栓塞术, 术中视门静脉压力情况行经TIPS术;对于存在门-体异常分流道患者, 行球囊阻断逆行经静脉闭塞术(BRTO)+ TIPS, 治疗后随访6个月, 观察患者的临床预后。结果 直接介入治疗组患者的出血病变血管检出率为78%, 治疗有效率为78%;7 d、30 d、3个月、6个月内再出血率分别为23%、45%、45%、45%;7 d内、30 d内、3个月内、6个月内病死率分别为15%、28%、28%、28%。补救性介入治疗组患者DSA出血病变血管检出率为6/8, 治疗有效率为6/8;7 d、30 d、3个月、6个月内再出血率分别为1/8、4/8、4/8、4/8;7 d内、30 d内、3个月内、6个月内病死率分别为1/8、3/8、3/8、3/8。介入治疗后患者转氨酶、白蛋白、总胆红素和凝血功能指标均比治疗前好转(P均< 0.05), Child-Pugh评分及终末期肝病模型评分均低于治疗前(P均< 0.05)。结论 ASVUGIB是临床常见的危急症, 早发现、早干预、早治疗可改善患者预后, 介入栓塞治疗可作为存在胃镜治疗相对禁忌或胃镜治疗失败的ASVUGIB患者的治疗选择。 相似文献
3.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(1):21-31
AimThis review aims to summarize and discuss some of the most relevant clinical trials in epidemiology, diagnostics, and treatment of hypertension published in 2020 and 2021.Data synthesisThe trials included in this review are related to hypertension onset age and risk for future cardiovascular disease, reliability of different blood pressure monitoring methods, role of exercise-induced hypertension, treatment of hypertension in patients with SARS-CoV-2 infection, management of hypertension high-risk patient groups, e.g., in the elderly (≥80 years) and patients with atrial fibrillation, and the interplay between nutrition and hypertension, as well as recent insights into renal denervation for treatment of hypertension.ConclusionsHypertension onset age, nighttime blood pressure levels and a riser pattern are relevant for the prognosis of future cardiovascular diseases. The risk of coronary heart disease appears to increase linearly with increasing exercise systolic blood pressure. Renin-angiotensin system blockers are not associated with an increased risk for a severe course of COVID-19. In elderly patients, a risk-benefit assessment of intensified blood pressure control should be individually evaluated. A J-shaped association between cardiovascular disease and achieved blood pressure could also be demonstrated in patients with atrial fibrillation on anticoagulation. Salt restriction and lifestyle modification remain effective options in treating hypertensive patients at low cardiovascular risk. Sodium glucose co-transporter 2 inhibitors and Glucagon-like peptide-1 receptor agonists show BP-lowering effects. Renal denervation should be considered as an additional or alternative treatment option in selected patients with uncontrolled hypertension. 相似文献
4.
5.
《Indian heart journal》2022,74(6):474-477
Background and objectivesAmbulatory blood pressure (BP) monitoring has become useful in the diagnosis and management of hypertensive individuals. In this study we tried to know the role of office and ambulatory BP in treated hypertensive patients.Methods and patientsProspective cohort of 561 treated hypertensive patients were enrolled in the study. Hypertension definitions were according to JNC 8 classification. Office BP and ambulatory BP monitoring was done according to defined protocol.ResultsFrom a subgroup of 158 treated hypertensive patients, 91(16.2%) patients were having white coat hypertension (p value 0.00 by Pearson chi square test). In a subset of 403 patients who were having controlled BP on the day of enrolment as well as on the day of attaching ambulatory BP monitor; 98 (17.4%) patients were having masked uncontrolled hypertension (MUCH). In addition there was very significant percentage of non-dippers and reverse dippers. In our study we found that office BP has a moderate to low specificity and sensitivity and low negative predictive value for overall control in treated hypertensive patients.ConclusionAmbulatory BP monitoring should be included in the management protocol of treated hypertensive patients, for the optimal BP control. 相似文献
6.
《Revista portuguesa de cardiologia》2022,41(4):311-320
Aims and objectivesVitamin D deficiency is a common finding and there is a suggested association with hypertension. Resistant hypertension is a clinical problem observed in 5–30% of hypertensive patients. Renal denervation (RDN) has been used for patients with resistant hypertension and has proven to lower blood pressure. Our primary goal was to assess the vitamin D serum concentration as a predictor of blood pressure response to RDN in highly selected patients.MethodsThis prospective, nonrandomized, single-center study included 24 patients treated with RDN. Based on their one-year response after RDN, patients were classified as responders or non-responders at six months or at 12 months.ResultsThe median follow-up was 52 months (range, 14-91 months). After RDN, 17 patients (70.8%) had a reduction >5 mmHg in the mean systolic blood pressure, at the first six months of follow-up. At 12 months, 20 patients (83.3%) were responders. Vitamin D levels at baseline (15.1±4.8 vs. 24.2±8.8 ng/ml) and at six months (16.6±7.2 vs. 25±9.2 ng/ml) were lower in early non-responders compared to early responders (p=0.008), without significant variation during follow-up. Even though Vitamin D levels were lower in the total responder's group, no statistically significant differences were found (p=ns).ConclusionIn patients with resistant hypertension, low vitamin D concentrations were associated with an absence of early response to RDN. 相似文献
7.
8.
张宽友 《中国医疗器械信息》2022,(1)
目的:分析简易智能心率血压监测仪在老年难治性高血压合并冠心病患者中对血压控制效果的作用。方法:抽取2018年1月~2020年1月在本院接收的90例老年难治性高血压合并冠心病患者作为研究对象,根据抽签法进行分组,将患者分为观察组(n=45)和对照组(n=45)。对照组患者实施随机固定某时段监测,观察组采用简易智能心率血压监测仪进行全天候动态监测,观察比较两组患者的血压控制效果及心率改变情况。比较观察组和对照组患者日夜血压水平变化异常率及晨峰出现率。比较两组患者对于血压检查的满意度及舒适度。结果:观察组患者的全天血压、日间血压、夜间血压与全天血压总负荷水平均较对照组高,组间比较有较大的差别(P<0.05),同时观察组患者的日夜水平变化异常分型中非杓型较对照组低,而晨峰出现概率较对照组更高,组间比较有较大的差别(P<0.05),此外观察组患者对于血压检查的满意度及舒适度均明显高于对照组,组间比较有较大的差别(P<0.05)。结论:简易智能心率血压监测仪进行血压监测能够更好地发现血压异常状况,指导临床调整用药方案,有助于提高血压控制效果。 相似文献
9.
10.
目的探讨血清鸢尾素在老年稳定期慢性阻塞性肺病相关肺动脉高压(COPD-PH)中的临床价值。方法选择2019年5月—2021年5月在上海市浦东新区浦南医院呼吸科就诊的老年COPD患者及健康体检者为研究对象,分为对照组(A组)、稳定期COPD组(B组)和COPD-PH组(C组)。根据心超测定肺动脉收缩压(PASP)结果,将C组分为轻度(C1组)、中度(C2组)和重度(C3组)3个亚组。所有研究对象均测定肺动脉收缩压(PASP)、血清鸢尾素、血浆IL-6、血浆IL-8、血浆NT-Pro BNP、动脉血气,记录患者肺功能和CAT问卷评分;比较各组各指标值间的差异。结果 A、B、C组两两比较以及C1、C2、C3组两两比较,PASP、血清鸢尾素、血浆IL-6、血浆IL-8、血浆NT-Pro BNP、pH值、PaO;、PaCO;、FEV1%、FEV1/FVC、CAT评分各指标之间的差异均有统计学意义(P<0.05)。在A、B、C组以及C1、C2、C3组,血清鸢尾素与PASP、血浆IL-6、血浆IL-8、血浆NT-ProBNP、PaCO;、CAT评分均呈负相关性,与pH值、PaO;、FEV1%、FEV1/FVC均呈正相关性。结论老年稳定期COPD患者血清鸢尾素水平明显低于健康体检者;随着肺动脉压力逐渐增高,COPD-PH患者血清鸢尾素水平逐渐降低。 相似文献